radioligand therapy for mcrpc
Published 4 years ago • 854 plays • Length 2:18Download video MP4
Download video MP3
Similar videos
-
4:47
advances in psma radioligand therapy for mcrpc
-
1:47
challenges in radioligand therapy for patients with mcrpc
-
2:45
arrow: psma-targeted radioligand therapy plus enzalutamide in mcrpc
-
2:10
integrating radioligand therapy for prostate cancer in us clinical practice
-
4:34
emerging treatments for mcrpc
-
1:49
radioligands in the future of prostate cancer treatment
-
2:39
prospects and progress of treatments for mcrpc
-
11:54
chemotherapy and radioligand therapy for advanced prostate cancer
-
0:44
remaining questions regarding psma radioligand therapies
-
2:34
first-line treatments for patients with mhspc and mcrpc
-
0:45
should radioligand therapies be used in earlier settings in prostate cancer?
-
2:04
radioligand therapy advancements in prostate cancer
-
2:56
psma pet ratio predicts response to [177lu]psma radioligand therapy: a multicenter study
-
1:22
treatment for advanced prostate cancer patients | lutetium 177 psma radioligand therapy | mercy
-
4:28
targeted radioligand therapy for psma , metastatic castration-resistant prostate cancer
-
15:35
lu-psma radioligand therapy
-
2:02
unanswered questions regarding the use of parp inhibitors for patients with mcrpc
-
7:44
vision trial supports lupsma-targeting therapy for mcrpc | michael morris
-
5:27
177lu-psma-617 radionuclide therapy in mcrpc